Jyong Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.13	0.1	0.18	0.72	0.55	3.56
Short-Term Investments	16.88	-	-	0.09	1.83	0.66
Cash & Short-Term Investments	17.01	0.1	0.18	0.81	2.39	4.22
Cash Growth	17615.63%	-44.63%	-78.20%	-65.95%	-43.51%	-
Other Current Assets	0.16	0.11	1.66	1.65	0.26	2
Total Current Assets	17.16	0.21	1.84	2.46	2.65	6.22
Net Property, Plant & Equipment	3.45	3.19	3.54	6	6.78	6.61
Other Long-Term Assets	17.06	2.97	2.87	0.28	0.01	0.01
Total Assets	37.67	6.37	8.25	8.75	9.43	12.84
Accounts Payable	0	0	0	0	0.05	0.03
Accrued Expenses	1.21	1.35	1.18	0.89	1.06	0.79
Short-Term Debt	22.44	7.23	7.9	7.17	4.76	4.66
Current Portion of Long-Term Debt	0.35	0.06	0.08	0.48	0.18	0.17
Current Portion of Leases	0.13	0.16	0.13	0.17	0.25	0.13
Other Current Liabilities	3.43	3.33	4.97	4.2	0	0
Total Current Liabilities	27.55	12.13	14.26	12.91	6.29	5.78
Long-Term Debt	12.27	10.68	8.52	6.32	6.26	7.62
Long-Term Leases	0.01	0.02	0.07	0.12	0.35	0.36
Other Long-Term Liabilities	20.31	20.06	19.47	19.04	19.86	18.29
Total Long-Term Liabilities	32.59	30.76	28.06	25.47	26.46	26.27
Total Liabilities	60.14	42.89	42.32	38.38	32.76	32.05
Common Stock	0	0	0	0	0	0
Treasury Stock	-16.37	-16.37	-16.37	-16.37	-16.37	-16.37
Additional Paid-in Capital	28.26	11.81	11.81	11.81	11.81	11.81
Accumulated Other Comprehensive Income	-0.04	1.12	0.55	0.59	0.27	0.19
Retained Earnings	-34.33	-33.08	-30.06	-25.66	-19.03	-14.83
Shareholders' Equity	-22.47	-36.52	-34.07	-29.63	-23.33	-19.2
Total Liabilities & Equity	37.67	6.37	8.25	8.75	9.43	12.84
Total Debt	35.19	18.14	16.69	14.25	11.79	12.94
Net Cash (Debt)	-18.19	-18.04	-16.51	-13.44	-9.4	-8.72
Net Cash Per Share	-0.25	-0.25	-0.23	-0.19	-0.13	-0.12
Book Value	-22.47	-36.52	-34.07	-29.63	-23.33	-19.2
Book Value Per Share	-0.31	-0.51	-0.48	-0.41	-0.33	-0.27
Tangible Book Value	-22.47	-36.52	-34.07	-29.63	-23.33	-19.2
Tangible Book Value Per Share	-0.31	-0.51	-0.48	-0.41	-0.33	-0.27

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q